dovitinib
Showing 1 - 25 of 51
Advanced Solid Tumors Trial in Huntersville, Cleveland (2X-121 and dovitinib)
Recruiting
- Advanced Solid Tumors
- 2X-121 and dovitinib
-
Huntersville, North Carolina
- +1 more
Feb 1, 2023
Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,
Completed
- Adenocarcinoma of the Pancreas
- +3 more
- dovitinib lactate
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Hormone Refractory Prostate Cancer Trial in Seoul (TKI258)
Completed
- Hormone Refractory Prostate Cancer
-
Seoul, Chongro-ku, Korea, Republic of
- +1 more
Feb 16, 2021
Advanced Solid Tumors, Excluding Breast Cancer Trial in Worldwide (dovitinib (TKI258), fluvoxamine)
Completed
- Advanced Solid Tumors, Excluding Breast Cancer
- dovitinib (TKI258)
- fluvoxamine
-
Bronx, New York
- +5 more
Dec 17, 2020
Advanced Solid Tumors, Excluding Breast Cancer Trial in United States (caffeine, diclofenac, omeprazole)
Completed
- Advanced Solid Tumors, Excluding Breast Cancer
- caffeine
- +4 more
-
Kansas City, Kansas
- +4 more
Dec 17, 2020
Tumors, Cancer, Tumors Trial in United States (TKI258 (dovitinib))
Completed
- Neoplasms
- +2 more
- TKI258 (dovitinib)
-
Duarte, California
- +3 more
Dec 17, 2020
Solid Tumors Trial in Hospitalet de Llobregat, Fuenlabrada, Madrid (Dovitinib, Dovitinib + Paclitaxel)
Terminated
- Solid Tumors
- Dovitinib
- Dovitinib + Paclitaxel
-
Hospitalet de Llobregat, Barcelona, Spain
- +2 more
Apr 15, 2020
Gastric Cancer Trial in Seoul (Dovitinib)
Completed
- Gastric Cancer
- Dovitinib
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 6, 2020
Gastrointestinal Stromal Tumors Trial in Seoul, (dovitinib)
Completed
- Gastrointestinal Stromal Tumors
- dovitinib
-
Seoul,, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jan 6, 2020
Solid Tumors, Hepatic Impairment Trial in Worldwide (Dovitinib)
Completed
- Solid Tumors
- Hepatic Impairment
- Dovitinib
-
Los Angeles, California
- +11 more
Dec 17, 2020
Breast Cancer Trial in Houston (Dovitinib)
Completed
- Breast Cancer
- Dovitinib
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jul 22, 2019
Advanced Solid Tumors, Excluding Breast Cancer Trial in United States (TKI258)
Completed
- Advanced Solid Tumors
- Excluding Breast Cancer
-
Duarte, California
- +13 more
Dec 17, 2020
Prostate Cancer Trial in Houston (Dovitinib, Abiraterone Acetate, Prednisone)
Terminated
- Prostate Cancer
- Dovitinib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 26, 2019
Recurrent ACC, metastaticACC, Unreaectable ACC Trial in Seoul (Axitinib, Observation)
Completed
- Recurrent ACC, metastaticACC, Unreaectable ACC
- Axitinib
- Observation
-
Seoul, Korea, Republic ofDepartment of Internal Medicine, Seoul National University Hospi
Mar 26, 2022
Adenoid Cystic Carcinoma Trial in Charlottesville (Dovitinib (TKI258))
Completed
- Adenoid Cystic Carcinoma
- Dovitinib (TKI258)
-
Charlottesville, VirginiaUniversity of Virginia Health System
Oct 12, 2018
Cancer Target Therapy Efficacy
Active, not recruiting
- Cancer
- RNA sequencing
- +5 more
-
Walnut, California
- +6 more
Sep 13, 2021
Breast Cancer Trial in Washington (Dovitinib, Aromatase Inhibitors)
Terminated
- Breast Cancer
- Dovitinib
- Aromatase Inhibitors
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Jan 15, 2018
NSCLC, Colorectal Cancer Trial in Sacramento (Dovitinib)
Completed
- Non-Small Cell Lung Cancer
- Colorectal Cancer
- Dovitinib
-
Sacramento, CaliforniaUniversity of California Comprehensive Cancer Center
Jan 5, 2018
Gastric Cancer Trial in Seoul (Dovitinib and docetaxel)
Completed
- Gastric Cancer
- Dovitinib and docetaxel
-
Seoul, Korea, Republic ofAsan Medical Center
Jul 13, 2017